William WerkmeisterJan 8, 20232 minBoston Scientific (NYSE:BSX) Shares Fell over 3% Following the Release of SCOPE II Trial Data at TCTBoston Scientific (NYSE:BSX) shares fell over 3% following the release of SCOPE II trial data at TCT Connect 2020. The data showed that...